Oppenheimer Provides Update On Synutra (SYUT)

Oppenheimer released its quarterly update for Synutra International Inc. SYUT. Oppenheimer stated that, "Synutra delivered another strong quarter with revenue and EPS handsomely beating our estimates by 5% and 19%." In addition, Oppenheimer feels Synutra's stellar results will likely take a back seat to SYUT's infant precocious puberty issue.